The ministry of health has decided to revoke the registration of two Indian companies that supplied substandard pharmaceutical drugs.
Director of the cosmetics, devices and drugs regulatory authority Dr. Hemantha Benaragama stated that this decision was taken following an investigation carried out by a group of officials from the Ministry of Health who had travelled to India.
Meanwhile, the ministry of health has decided to obtain expert opinions on two pharmaceutical drugs administered to patients with Thalassemia, which are Desferal and Talifer.
Various reports were published recently that following the administration of these drugs children suffering from Thalassemia had suffered various physical complications.
According to the Ministry of health, based on these reports the Minister of health Maithreepala Sirisena has issued instructions to the ministry's additional secretary Dr. Palitha Maheepala to obtain the opinion of experts.
Therefore following a discussion with a panel of experts including several specialist doctors a decision will be taken regarding the administration of either both drugs or just one.